Protecting Your Investments: Kaplan Fox Investigates Potential Securities Fraud at Spectrum Pharmaceuticals Inc.
Spectrum Pharmaceuticals, Inc. Shareholder Alert: Kaplan Fox Investigates Potential Securities Claims Kaplan Fox & Kilsheimer LLP Investigates Claims on Behalf of Spectrum Pharmaceuticals, Inc. Investors NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP is currently investigating claims on behalf of investors in Spectrum Pharmaceuticals, Inc. (“Spectrum” or the “Company”) (NASDAQ:…